Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Gynecologic Oncology
  Follow Topic   Edit Search
Your search returned 8 results
from the time period: last 90 days.
Sort by Relevance / Date Group By Journal / No Grouping
Lancet (London, England) 
... Administration approved the antiangiogenesis drug bevacizumab for women with advanced cervical cancer on the basis of improved overall survival (OS) after the ... second interim analysis (in 2012) of 271 deaths in the Gynecologic Oncology Group (GOG) 240 trial... 3 trial, we recruited patients with metastatic, persistent, or recurrent cervical carcinoma from 81 centres in the USA, Canada, and Spain.
Oncology (6)
Fistula (3), Uterine Cervical Neoplasms (3), Carcinoma (1), more mentions
The Cochrane database of systematic reviews 
... pelvic lymphadenectomy on lymphocyst formation and related morbidities in women with gynaecological cancer AbstractText: We searched the Cochrane Central Register of Controlled Trials (CENTRAL ... retroperitoneal drainage versus no drainage after pelvic lymphadenectomy in women with gynaecological cancer... the prevention of lymphocyst formation after pelvic lymphadenectomy in women with gynaecological malignancies.
Oncology (2)
Neoplasms (2), more mentions
BMJ supportive & palliative care 
... improved cancer-specific quality of life for women following curative treatment for stage I-III gynaecological cancer AbstractText: Consecutive women were invited to participate in a randomised controlled study (HNA and care ... professional is cost-effective, acceptable and useful for some women treated for stage I-III gynaecological cancer... Keyword: gynaecological cancer.
Oncology (9)
Neoplasms (9), more mentions
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 
Abstract: Purpose In the United States, 3.8 million women have a history of breast (BC) or ovarian cancer (OC. Up to 15% of cases are attributable to heritable mutations, which, if identified, provide critical knowledge for treatment and preventive care. It is unknown how many patients who are at high risk for these mutations have not been tested and how ...
Oncology (5)
Neoplasms (3), Ovarian Neoplasms (2), more mentions
The Cochrane database of systematic reviews 
AbstractText: Cervical cancer screening has traditionally been based on cervical cytology... 2+), including adenocarcinoma in situ, in women participating in primary cervical cancer screening; and how it compares to the accuracy of cytological ... The studies had to include women participating in a cervical cancer screening programme who were not being followed up for previous ...
Oncology (4)
Uterine Cervical Neoplasms (4), Adenocarcinoma (1), Infections (1), more mentions
The Journal of experimental medicine 
... these phenotypes via CD55, an intrinsic cell surface complement inhibitor, which was identified in a comparative analysis between CSCs and non-CSCs in endometrioid cancer models... node that drives self-renewal and therapeutic resistance through a bifurcating signaling axis and provides an opportunity to target both signaling pathways in endometrioid tumors.
Oncology (2)
Neoplasms (4), more mentions
Cell 
DescriptorName: Ovarian Neoplasms... Abstract: We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases ...
Oncology (5)
Neoplasms (5), Ovarian Neoplasms (3), Neoplasm Metastasis (1), more mentions
Scientific reports 
High-throughput technologies have identified significant changes in patterns of mRNA expression over cancer development but the functional significance of these changes often rests upon the assumption that observed changes in levels of mRNA accurately reflect changes in levels of their encoded proteins. We systematically compared the expression of 4436 genes on the RNA and protein levels between discrete tumor samples collected from the ovary and from the omentum of the same OC patient. The overall correlation between global changes in levels of mRNA and their encoding proteins is low (r = 0.38). The majority of differences are on the protein level with no corresponding change on the mRNA level. Indirect and direct evidence indicates that a significant fraction of the differences may be mediated by microRNAs.
Oncology (2)
Neoplasms (2), Ovarian Neoplasms (1), more mentions